Browse EX-10 agreements

H2O AMERICA

THIRD AMENDED AND RESTATED FORMULAIC EQUITY AWARD PROGRAM FOR NON-EMPLOYEE BOARD MEMBERS

I.IMPLEMENTATION

This Third Amended and Restated Formulaic Equity Award Program for Non-Employee Board Members (the “Automatic Grant Program”) is implemented under the H2O America (the “Corporation”) 2023 Long-Term Incentive Plan (the “Plan”) and shall become effective as of January 1, 2027.

Unless indicated to the contrary, all capitalized terms in this Automatic Grant Program shall have the meanings assigned to them in the Appendix to the Plan.

II.AWARD TERMS

A.Automatic Grants.    The Awards to be made pursuant to the Automatic Grant Program shall be as follows:

…

H2O AMERICA

AMENDED AND RESTATED DIRECTOR COMPENSATION AND

EXPENSE REIMBURSEMENT POLICIES

Effective as of January 1, 2027

I.    DIRECTOR COMPENSATION

A.    ROLE OF THE EXECUTIVE COMPENSATION COMMITTEE

    H2O America (the “Corporation”) Board of Directors (the “Board”), through its Executive Compensation Committee, will review, or request management or outside consultants to review, appropriate compensation policies for the directors serving on the Board and its committees. This review may consider board compensation practices of other similar public companies, contributions to Board functions, service as committee chairs, and other appropriate factors.

B.     COMPENSATION POLICIES

        1.    Annual Retainer

The Corporation shall pay the members of its Board who are not employed by the Corporation or any of its subsidiaries (each a “Non-Employee Director”) the following annual retainers:

…

HAEMONETICS CORPORATION

AMENDED AND RESTATED 2007 EMPLOYEE STOCK PURCHASE PLAN

On May 15, 2026 (the “Effective Date”), the Board of Directors adopted this Amended and Restated 2007 Employee Stock Purchase Plan (as amended from time to time, the “Plan”), which shall govern all grants of options under the Plan made after the Effective Date. For the terms and conditions of the Plan applicable to an Option granted before the Effective Date, refer to the version of the Plan in effect as of the date such option was granted.

1.Purpose

It is the purpose of this Plan to provide a means whereby eligible employees may purchase Common Stock of Haemonetics Corporation (the “Company”) through payroll deductions. It is intended to provide a further incentive for employees to promote the best interests of the Company and to encourage stock ownership by employees in order that they may participate in the Company's economic growth.

…

HAEMONETICS CORPORATION

AMENDED AND RESTATED 2019 LONG-TERM INCENTIVE COMPENSATION PLAN

Effective as of the Effective Date (as defined below), the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan, as previously amended and restated, is hereby amended and restated (as further amended and restated, the “Plan”).

The purpose of the Plan is to provide employees of Haemonetics Corporation, a Massachusetts corporation (the “Company”), and its subsidiaries, certain consultants and advisors who perform services for the Company and its subsidiaries, and non-employee members of the Board of Directors of the Company and its subsidiaries, with the opportunity to receive grants of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, other stock-based awards, and/or cash awards.

…

STANDSTILL AGREEMENT

This Standstill Agreement (this “Agreement”) is entered into as of July 28, 2026 (the “Effective Date”) by and between Streeterville Capital, LLC, a Utah limited liability company (“Investor”), and Professional Diversity Network, a Delaware corporation (“Company”). Capitalized terms used in this Agreement without definition shall have the meanings given to them in PPP #1 (defined below).

A.    Company previously sold and issued to Investor that certain Pre-Paid Purchase #1 dated September 5, 2025, as amended, in the original principal amount of $8,655,000.00 (the “PPP #1”) pursuant to that certain Securities Purchase Agreement dated September 5, 2025 by and between Investor and Company (the “Purchase Agreement”, and together with all other documents entered into in conjunction therewith, the “Transaction Documents”).

B.    Company has requested and Investor has agreed, subject to the terms, conditions and understandings expressed in this Agreement, to refrain and forbear temporarily from making purchases under PPP #1.

…

SECURITIES PURCHASE AGREEMENT

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and made effective as of [ ], 2026, between Professional Diversity Network, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act (as defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

ARTICLE I.
DEFINITIONS

…

Form of Lock-Up Agreement

[ ], 2026

Maxim Group LLC

300 Park Avenue, 16th Floor

New York, NY 10022

Ladies and Gentlemen:

The undersigned understands that Maxim Group LLC (the “Placement Agent”) proposes to enter into a Placement Agency Agreement (the “Agreement “) with Professional Diversity Network, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) of certain securities of the Company.

…

THIS PROMISSORY NOTE AND SECURITY AGREEMENT (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR UNDER ANY STATE SECURITIES LAW. IT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED EXCEPT PURSUANT TO THE PROVISIONS OF THE ACT AND APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL SATISFACTORY TO THE BORROWER THAT SUCH SALE, ASSIGNMENT, PLEDGE OR TRANSFER IS IN COMPLIANCE WITH AN AVAILABLE EXEMPTION UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS.

…

CERTAIN IDENTIFIED INFORMATION, MARKED BY [****], HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS OF THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL

THIRD AMENDMENT TO CREDIT AGREEMENT AND FORBEARANCE AGREEMENT

This THIRD AMENDMENT TO CREDIT AGREEMENT AND FORBEARANCE AGREEMENT (this “Amendment”) is entered into as of July 22, 2026, by and among AMERICAN SHARED HOSPITAL SERVICES, a California corporation (“ASHS”), PBRT ORLANDO, LLC, a Delaware limited liability company (“PBRT Orlando”), and GK FINANCING, LLC, a California limited liability company and indirect Subsidiary of ASHS (“GKF”; ASHS, PBRT Orlando and GKF are from time to time referred to herein individually as a “Borrower”* *and collectively as the “Borrowers”), FIFTH THIRD BANK, NATIONAL ASSOCIATION (“Lender”), and AMERICAN SHARED RADIOSURGERY SERVICES, a California corporation, as a Loan Party.

W I T N E S S E T H:

…

NOTE AND WARRANT PURCHASE AGREEMENT

This Note and Warrant Purchase Agreement, dated as of July 22, 2026 (this “Agreement”) is entered into between and among American Shared Hospital Services, a California corporation (the “Company” or the “Borrower”), and RCS/TIG Holdings LLC, a Delaware limited liability company (the “Lender”). Capitalized terms not otherwise defined herein shall have the meaning set forth in the form of Note (as defined below) or Warrant (as defined below) attached hereto as Exhibits A and B, respectively.

RECITALS

WHEREAS, the Borrower has requested that the Lender invest the sum of $2,000,000 (the “Loan”) in return for: (i) a promissory note in the principal amount of the Loan and (ii) certain warrants to purchase shares of Company Common Stock No Par Value (the “Common Stock”), and the Lender is willing to make the Loan on the terms and conditions set forth herein (the “Note and Warrant Purchase”);

…

CTO REALTY GROWTH, INC.
AMENDED AND RESTATED PERFORMANCE SHARE AWARD AGREEMENT

This AMENDED AND RESTATED Performance Share Award Agreement (this “Agreement”) is made as of the 24th day of July, 2026 (the “Effective Date”), by and between CTO REALTY GROWTH, INC., a Maryland corporation (the “Company”), and [GRANTEE NAME] (“Grantee”).

Background

The Company has adopted the Sixth Amended and Restated CTO Realty Growth, Inc. 2010 Equity Incentive Plan (the “Plan”), which is administered by the Compensation Committee (the “Committee”) of the Company’s Board of Directors (the “Board”).  Section 8 of the Plan provides that the Committee shall have the discretion and right to grant Performance Shares, subject to the terms and conditions of the Plan and any additional terms provided by the Committee.  The Committee granted Performance Shares to Grantee as of February 11, 2026 (the “Grant Date”) pursuant to the terms of the Plan and the Original Agreement (as defined below).  Grantee desires to ratify Grantee’s prior acceptance of the grant of Performance Shares and agrees to be bou

…

								Exhibit 10.1
								Mondelēz International Inc. Chicago, IL 60607 USA
								mondelezinternational.com

PRIVATEANDCONFIDENTIAL

Mr. Amit Banati

June 12, 2026

OFFER LETTER

DearAmit,

…